Serum proteomics using mass spectrometry

Methods in Molecular Biology

Volumn 520, Issue , 2009, Pages 107-128

  Hood, Brian L ^a   Malehorn, David E ^a   Conrads, Thomas P ^a   Bigbee, William L ^a  

^a UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

Author keywords

Abundant protein depletion; MALDI TOF MS; Nanoflow RPLC MS MS; Serum proteomics

Indexed keywords

PLASMA PROTEIN;

ARTICLE; HUMAN; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; METHODOLOGY; NANOTECHNOLOGY; PROTEOMICS;

BLOOD PROTEINS; CHROMATOGRAPHY, LIQUID; HUMANS; MASS SPECTROMETRY; NANOTECHNOLOGY; PROTEOMICS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 65649113948     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-60327-811-9_8     Document Type: Article

References (20)

1. Hauskrecht, M., Pelikan, R., Malehorn, D.E., Bigbee, W.L., Lotze, M.T., et al. (2005) Feature selection for classification of SELDI-TOF-MS proteomic profiles. Appl. Bioinfor-matics 4, 227-246. (Pubitemid 41737125)
2. Pelikan, R., Bigbee, W.L., Malehorn, D.E., Lyons-Weiler, J., and Hauskrecht, M. (2007) Intersession reproducibility of mass spec-trometry profiles and its effect on accuracy of multivariate classification models. Bioinfor-matics 23, 3065-3072. (Pubitemid 350162872)
3. Baggerly, K.A., Morris, J.S., Edmonson, S.R., and Coombes, K.R. (2005) Signal in noise: evaluating reported reproducibility of serum proteomic tests for ovarian cancer. J. Natl. Cancer Inst. 97, 307-309. (Pubitemid 40310279)
4. Tirumalai, R.S., Chan, K.C., Prieto, D.A., Issaq, H.J., Conrads, T. P., et al. (2003) Characterization of the low molecular weight human serum proteome. Mol. Cell. Proteomics 2, 1096-1103.
5. Washburn, M.P., Wolters, D., and Yates J.R. III. (2001) Large-scale analysis of the yeast pro-teome by multidimensional protein identification technology. Nat. Biotechnol. 19, 242-247. (Pubitemid 32220565)
6. McLerran, D., Grizzle, W.E., Feng, Z., Bigbee, W.L., Banez, L.L., et al. (2008) Analytical validation of serum proteomic profiling for diagnosis of prostate cancer: sources of sample bias. Clin. Chem. 54, 44-52. (Pubitemid 351182595)
7. Traum, A.Z., Wells, M.P., Aivado, M., Libermann, T.A., Ramoni, M.F., et al. (2006) SELDI-TOF MS of quadruplicate urine and serum samples to evaluate changes related to storage conditions. Proteomics 6, 1676-1680.
8. Villanueva, J., Philip, J., Chaparro, C.A., Li, Y., Toledo-Crow, R., et al. (2005) Correcting common errors in identifying cancer-specific serum peptide signatures. J. Proteome Res. 4, 1060-1072. (Pubitemid 41208664)
9. Whistler, T., Rollin, D., and Vernon, S.D. (2007) A method for improving SELDI-TOF mass spectrometry data quality. Proteome Sci. 5, 4-14.
10. Seam, N., Gonzales, D.A., Kern, S.J., Hortin, G.L., Hoehn, G.T., Suffredini, A.F. (2007) Quality control of serum albumin depletion for proteomic analysis. Clin. Chem. 53, 1915-1920. (Pubitemid 350036035)
11. Sundsten, T., Eberhardson, M., Goransson, M., and Bergsten, P. (2006) The use of proteom-ics in identifying differentially expressed serum proteins in humans with type 2 diabetes. Pro-teome Sci. 4, 4-22.
12. Villanueva, J., Lawlor, K., Toledo-Crow, R., and Tempst, P. (2006) Automated serum pep-tide profiling. Nat. Protoc. 1, 880-891.
13. Aivado, M., Spentzos, D., Alterovitz, G., Out, H.H., Grall. F., et al. (2005) Optimization and evaluation of surface-enhanced laser desorption/ionization time-of-flight mass spectrometry (SELDI-TOF MS) with reversed-phase protein arrays for protein profiling. Clin. Chem. Lab. Med. 43, 133-140. (Pubitemid 40361458)
14. McLerran, D., Grizzle, W.E., Feng, Z., Thompson, I.M., Bigbee, W.L., et al. (2008) SELDI-TOF MS whole serum proteomic profiling with IMAC surface does not reliably detect prostate cancer. Clin. Chem. 54, 53-60. (Pubitemid 351182596)
15. Baggerly, K.A., Coombes, K.R., and Morris, J.S. (2005) Bias, randomization and ovarian proteomic data: A reply to "Producers and Consumers." Canc. Informatics 1, 9-14.
16. Semmes, O.J., Feng, Z., Adam, B.L., Banez, L.L., Bigbee, W.L., et al. (2005) Evaluation of serum protein profiling by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry for the detection of prostate cancer: I. Assessment of platform reproduc-ibility. Clin. Chem. 51, 102-112. (Pubitemid 40024018)
17. Villanueva, J., Philip, J., DeNoyer, L., and Tempst, P. (2007) Data analysis of assor ted serum peptidome profiles. Nat. Protoc. 2, 588-602. (Pubitemid 47040021)
18. Hendriks, M.M., Smit, S., Akkermans, W.L., Reijmers, T.H., Eilers, P.H., et al. (2007) How to distinguish healthy from diseased? Classification strategy for mass spectrometry-based clinical proteomics. Proteomics 7, 3672-3680. (Pubitemid 350022273)
19. Wong, J.W., Cagney, G., and Cartwright, H.M. (2005) SpecAlign-processing and alignment of mass spectra datasets. Bioinformatics 21, 2088-2090. (Pubitemid 40668050)
20. Au, J.S.K., Cho, W.C.X., Yip, T.T., Yip, C., Zhu, H., et al. (2007) Deep proteome profiling of sera from never-smoked lung cancer patients. Biomed. Pharmacother. 61, 570-577. (Pubitemid 47562695)